InvestorsHub Logo
Followers 165
Posts 12947
Boards Moderated 1
Alias Born 01/26/2016

Re: jesster64 post# 368881

Monday, 04/12/2021 10:12:20 PM

Monday, April 12, 2021 10:12:20 PM

Post# of 703658
jesster64,

Charles Rivers Labs projects 25% year over year growth after acquiring Cognate but .. hold on one second ..there will be an update to this statement sometime this Spring. Oh by the way, Cognate announced a doubling of manufacturing capacity and then Charles Rivers Labs says they will be increasing manufacturing space in this same space too. Now Cognate, the primary manufacturer of DCVax-L for more than 8 years including during the transition from a Phase 2 to Phase 3 trial that completed enrollment in 2015, made their announcement during data lock and expected unblinding to NWBO, who does not manufacture DCVax-L but relies on Cognate to do so, somehow saw the need to increase manufacturing capacity 100% ASAP and subsequently was bought out by another company that wanted to expand capacity even more. I’d say it looks like the horse left the barn ; ). Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News